Accueil>>MitoNeoD

MitoNeoD (Synonyms: MitoNeoD; Mito-NeoD; Mito Neo D; Mito-Neo-D; Mito Neo-D)

Catalog No.GB62268

MitoNeoD is a novel mitochondria-targeted O2(⋅-) probe that can be used in vivo.

Products are for research use only. Not for human use. We do not sell to patients.

MitoNeoD Chemical Structure

Cas No.: 2375088-89-2

Taille Prix Stock
1mg Please Inquire Please Inquire
2mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire
10mg Please Inquire Please Inquire
25mg Please Inquire Please Inquire
50mg Please Inquire Please Inquire
100mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

MitoNeoD is a novel mitochondria-targeted O2(⋅-) probe that can be used in vivo. It prevents DNA intercalation. MitoNeoD incorporates a carbon-deuterium bond, and enhances O2(⋅-) selectivity. MitoNeoD comprises a O2⋅--sensitive reduced phenanthridinium moiety modified to prevent DNA intercalation, as well as a carbon-deuterium bond to enhance its selectivity for O2⋅- over non-specific oxidation, and a triphenylphosphonium lipophilic cation moiety leading to the rapid accumulation within mitochondria. MitoNeoD is a versatile and robust probe to assess changes in mitochondrial O2⋅- from isolated mitochondria to animal models, thus offering a way to examine the many roles of mitochondrial O2⋅- production in health and disease.

Avis

Review for MitoNeoD

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MitoNeoD

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.